International RUNX Workshop
国际RUNX研讨会
基本信息
- 批准号:8129107
- 负责人:
- 金额:$ 1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-07-01 至 2011-12-31
- 项目状态:已结题
- 来源:
- 关键词:Acute Myelocytic LeukemiaAreaBindingBiologicalBiological ModelsBiologyBloodBlood PlateletsBone DiseasesBrainCaliforniaCancer BiologyCell SurvivalCellsChromosomal translocationChromosome abnormalityCollaborationsComplexDNADNA BindingDevelopmentDevelopmental BiologyDisabled PersonsDisciplineDiseaseDrosophila genusEducational workshopEmbryoEnvironmentEyeFamilyFamily memberFishesFriendshipsFunctional disorderFutureGene ExpressionGenesGeneticGroup MeetingsHairHematopoiesisHumanInternationalKnowledgeMalignant NeoplasmsMentorsModelingMusMutationNormal CellPathway interactionsPlayProcessProteinsRUNX1 geneRegulationResearchResearch ActivityResearch PersonnelResource SharingResourcesRoleScienceScientistSocietiesSolid NeoplasmStem cellsStructureSystemSystems BiologyTherapeuticTherapeutic InterventionUnderrepresented MinorityUnited States National Institutes of HealthVertebratesWorkbasebody systembonecancer stem cellcareercell behaviorcell fate specificationdrug discoveryhuman diseaseinterestleukemialeukemia/lymphomameetingsnovelosteosarcomaprogramsrole modelskeletal disorderstemstem cell differentiationstem cell fatestructural biologysymposiumt(821)(q22q22)transcription factorvirologyworking group
项目摘要
DESCRIPTION (provided by applicant): This application is to request partial support from the National Institutes of Health for the "18th International RUNX Workshop". The workshop will take place in La Jolla, California in August of 2011. The meeting will bring together scientists around the world working in a variety of scientific fields and using different model systems to discuss the role of the RUNX family of transcription factors in normal cell behavior and human disease development, and to discuss therapeutic approaches for RUNX-related diseases, such as leukemia, solid tumors, familial platelet problems and bone disorders. With the exception of the RUNX workshop, most of the attending scientists do not have any opportunities to meet in other scientific conferences, due to the extremely diversified areas of research. The significance of this family of transcription factors stems from their function as master regulators of multiple cellular programs during development and differentiation, and from their dominant function when altered in the development of cancer. This workshop has been organized annually since 1994. It provides a unique forum for the exchange of ideas and resources across biological disciplines and model systems. The attendance has increased markedly from the five research groups that met in the inaugural workshop at Dartmouth in 1994 to include 120 investigators in recent years. According to our current knowledge of RUNX function and the most exciting areas of ongoing research activities, the upcoming 18th International RUNX Workshop will focus on following areas: 1) Stem cell survival and expansion; 2) Mechanisms of cell-fate specification in development and differentiation; 3) Hematopoiesis, leukemia and lymphoma; 4) Cancer and cancer stem cells; 5) Bone biology, osteosarcomas and skeletal disorders; and 6) Systems biology, structure biology and drug discovery. Based on the long-standing interactive and inter-disciplinary traditions of the 17 previous RUNX workshops, we anticipate that the 18th International RUNX Workshop will offer excellent opportunities for the cross-pollination of ideas and the development of new collaborations in this rapidly expanding field.
PUBLIC HEALTH RELEVANCE: RUNX proteins play key regulatory roles in a number of essential developmental pathways. Importantly, perturbations in RUNX function have been shown to be causally associated with a number of different human diseases, including effects on the differentiation of stem cells in multiple lineages and the development of a variety of leukemias, solid tumors and bone disorders. The complexity in their expression, regulation and function has made the RUNX genes a focus of study of several fields of research, including developmental biology, virology, genetics, structural biology, cancer biology, systems biology and more recently in therapeutic interventions.
描述(由申请人提供):本申请是为“第18届国际Runx研讨会”请求全国卫生研究院的部分支持。该研讨会将于2011年8月在加利福尼亚州的拉霍亚举行。会议将召集世界各地的科学家在各种科学领域工作,并使用不同的模型系统讨论Runx转录因子家族在正常细胞行为和人类疾病发展中的作用,并讨论与Runx相关的疾病的治疗方法,例如,属于RUNX相关的疾病,例如固体肿瘤,固体肿瘤,骨骼,骨骼疾病,骨骼疾病和骨骼问题。除Runx研讨会外,由于研究领域极为多样化,大多数参加的科学家在其他科学会议上没有任何机会。这种转录因子家族的重要性源于它们在开发和分化过程中作为多个细胞程序的主要调节剂的功能,以及在癌症发展发生变化时的主要功能。自1994年以来,该研讨会每年都会组织。它为跨生物学学科和模型系统的思想和资源提供了一个独特的论坛。 1994年在达特茅斯(Dartmouth)在达特茅斯(Dartmouth)首届研讨会上相遇的五个研究小组的出席率显着提高,近年来包括120名调查人员。根据我们目前对Runx功能的了解以及正在进行的研究活动的最令人兴奋的领域,即将举行的第18届国际Runx研讨会将重点放在以下领域上:1)干细胞的生存和扩张; 2)开发和分化中细胞命令规范的机制; 3)造血,白血病和淋巴瘤; 4)癌症干细胞; 5)骨骼生物学,骨肉瘤和骨骼疾病; 6)系统生物学,结构生物学和药物发现。基于以前17个Runx研讨会的长期互动和跨学科的传统,我们预计第18届国际Runx研讨会将为思想的交叉授粉和在这个迅速扩展的领域的新合作发展提供绝佳的机会。
公共卫生相关性:RUNX蛋白在许多基本发展途径中扮演关键的监管角色。重要的是,RUNX功能的扰动已被证明与许多不同的人类疾病有因果关系,包括对多个谱系中干细胞分化的影响以及多种白血病,实体瘤和骨骼疾病的发展。其表达,调节和功能的复杂性使RunX基因成为研究多个研究领域的重点,包括发育生物学,病毒学,遗传学,结构生物学,癌症生物学,系统生物学以及最近的治疗干预措施。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DONG-ER ZHANG其他文献
DONG-ER ZHANG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DONG-ER ZHANG', 18)}}的其他基金
CSF2 receptor mediated actions in t(8;21) leukemia
CSF2 受体介导的 t(8;21) 白血病作用
- 批准号:
9014529 - 财政年份:2015
- 资助金额:
$ 1万 - 项目类别:
CSF2 receptor mediated actions in t(8;21) leukemia
CSF2 受体介导的 t(8;21) 白血病作用
- 批准号:
8842430 - 财政年份:2015
- 资助金额:
$ 1万 - 项目类别:
Synergestic roles of SRF2 and RUNX1 in blood cell development and pathology
SRF2 和 RUNX1 在血细胞发育和病理学中的协同作用
- 批准号:
10400021 - 财政年份:2013
- 资助金额:
$ 1万 - 项目类别:
ISG15 and protein ISGylation in Cancer
癌症中的 ISG15 和蛋白质 ISGylation
- 批准号:
8616739 - 财政年份:2013
- 资助金额:
$ 1万 - 项目类别:
ISG15 and protein ISGylation in Cancer
癌症中的 ISG15 和蛋白质 ISGylation
- 批准号:
8535417 - 财政年份:2013
- 资助金额:
$ 1万 - 项目类别:
Synergestic roles of SRF2 and RUNX1 in blood cell development and pathology
SRF2 和 RUNX1 在血细胞发育和病理学中的协同作用
- 批准号:
9922899 - 财政年份:2013
- 资助金额:
$ 1万 - 项目类别:
相似国自然基金
定向金属结合区域的倒捻子素类PDE4抑制剂:类药性优化及抗肺纤维化作用研究
- 批准号:22277019
- 批准年份:2022
- 资助金额:54.00 万元
- 项目类别:面上项目
定向金属结合区域的倒捻子素类PDE4抑制剂:类药性优化及抗肺纤维化作用研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
高光谱遥感与地面观测数据结合的区域甘蔗糖分估算研究
- 批准号:42105175
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
ERβ结合区域遗传变异与结直肠癌发病风险的机制研究
- 批准号:
- 批准年份:2020
- 资助金额:57 万元
- 项目类别:面上项目
基于“区域资源高效协同机制”作用的医养结合养老社区中医疗功能空间配置研究
- 批准号:
- 批准年份:2020
- 资助金额:58 万元
- 项目类别:面上项目
相似海外基金
Direct chemical control of the hematopoietic master transcription factor PU.1
造血主转录因子 PU.1 的直接化学控制
- 批准号:
10540346 - 财政年份:2021
- 资助金额:
$ 1万 - 项目类别:
Synthetic Strategies to Restore the Efficacy of Venetoclax in Acute Myeloid Leukemia
恢复 Venetoclax 在急性髓系白血病中的疗效的综合策略
- 批准号:
10290284 - 财政年份:2021
- 资助金额:
$ 1万 - 项目类别:
Direct chemical control of the hematopoietic master transcription factor PU.1
造血主转录因子 PU.1 的直接化学控制
- 批准号:
10322390 - 财政年份:2021
- 资助金额:
$ 1万 - 项目类别: